98%
921
2 minutes
20
Background: The first wave of the London COVID-19 epidemic peaked in April 2020. Attention initially focused on severe presentations, intensive care capacity, and the timely supply of equipment. While general practice has seen a rapid uptake of technology to allow for virtual consultations, little is known about the pattern of suspected COVID-19 presentations in primary care.
Aim: To quantify the prevalence and time course of clinically suspected COVID-19 presenting to general practices, to report the risk of suspected COVID-19 by ethnic group, and to identify whether differences by ethnicity can be explained by clinical data in the GP record.
Design And Setting: Cross-sectional study using anonymised data from the primary care records of approximately 1.2 million adults registered with 157 practices in four adjacent east London clinical commissioning groups. The study population includes 55% of people from ethnic minorities and is in the top decile of social deprivation in England.
Method: Suspected COVID-19 cases were identified clinically and recorded using SNOMED codes. Explanatory variables included age, sex, self-reported ethnicity, and measures of social deprivation. Clinical factors included data on 16 long-term conditions, body mass index, and smoking status.
Results: GPs recorded 8985 suspected COVID-19 cases between 10 February and 30 April 2020.Univariate analysis showed a two-fold increase in the odds of suspected COVID-19 for South Asian and black adults compared with white adults. In a fully adjusted analysis that included clinical factors, South Asian patients had nearly twice the odds of suspected infection (odds ratio [OR] = 1.93, 95% confidence interval [CI] = 1.83 to 2.04). The OR for black patients was 1.47 (95% CI = 1.38 to 1.57).
Conclusion: Using data from GP records, black and South Asian ethnicity remain as predictors of suspected COVID-19, with levels of risk similar to hospital admission reports. Further understanding of these differences requires social and occupational data.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480178 | PMC |
http://dx.doi.org/10.3399/bjgp20X712601 | DOI Listing |
Cureus
August 2025
Department of Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, JPN.
Hemorrhagic cholecystitis (HC) is a rare but life-threatening condition. While anticoagulant therapy is a known risk factor, the coronavirus disease 2019 (COVID-19) has recently emerged as another trigger. We experienced a severe case of perforated HC complicated by hemoperitoneum in a patient presenting both risk factors.
View Article and Find Full Text PDFInt J Infect Dis
September 2025
Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway; Department of Microbiology, Haukeland University Hospital, Bergen, Norway. Electronic address:
Community-acquired pneumonia [CAP] is a leading cause of morbidity and mortality, often complicated by diagnostic uncertainty and antibiotic overuse. This study evaluated the MeMed BV® host-response test in adults with suspected CAP, using clinical management and molecular detection as reference standards. Among 744 patients presenting with suspected CAP at Haukeland University Hospital, Bergen, Norway (2019-2023), across three prospective studies, 453 were included in the present study.
View Article and Find Full Text PDFFront Vet Sci
August 2025
Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States.
Canine Infectious Respiratory Disease Complex (CIRDC), caused by a diverse range of viral and bacterial pathogens, is the leading cause of respiratory illness in dogs. In the winter of 2023-2024, the United States experienced a noticeable increase in cases consistent with CIRDC. This study investigated the potential association of emerging pathogens with CIRDC cases.
View Article and Find Full Text PDFDrug Saf
September 2025
Medicines and Healthcare products Regulatory Agency (MHRA), Safety and Surveillance, 10 South Colonnade, Canary Wharf, London, E14 4PU, UK.
Introduction: Yellow Card Vaccine Monitor (YCVM) was established by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to facilitate active monitoring of adverse drug reactions following COVID-19 vaccination and further characterise safety in populations under-represented in clinical trials.
Objective: This study explored the profile of individuals registered to the YCVM platform and the suspected adverse drug reactions reported following a COVID-19 vaccination on this data platform.
Methods: Using a stratified random selection approach, individuals were invited to register and actively contacted to seek further information on the vaccines received and adverse reactions they experienced.
BMC Public Health
September 2025
Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda.
Background: Cholera is endemic in Uganda with periodic outbreaks occurring annually. On July 24, 2023, Uganda's Ministry of Health confirmed a cholera outbreak in Sigulu Island, Namayingo District. We investigated to determine its magnitude, identify possible exposures, and recommend evidence-based control interventions.
View Article and Find Full Text PDF